Cargando…

Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital

BACKGROUND: The current study was undertaken to examine total hospital costs per patient of a consecutive implantation series of two 3(rd) generation Left Ventricle Assist Devices (LVAD). Further we analyzed if increased clinical experience would reduce total hospital costs and the gap between costs...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Vinod, Fiane, Arnt E, Geiran, Odd, Sørensen, Gro, Khushi, Ishtiaq, Hagen, Terje P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515474/
https://www.ncbi.nlm.nih.gov/pubmed/22925716
http://dx.doi.org/10.1186/1749-8090-7-76
_version_ 1782252188414771200
author Mishra, Vinod
Fiane, Arnt E
Geiran, Odd
Sørensen, Gro
Khushi, Ishtiaq
Hagen, Terje P
author_facet Mishra, Vinod
Fiane, Arnt E
Geiran, Odd
Sørensen, Gro
Khushi, Ishtiaq
Hagen, Terje P
author_sort Mishra, Vinod
collection PubMed
description BACKGROUND: The current study was undertaken to examine total hospital costs per patient of a consecutive implantation series of two 3(rd) generation Left Ventricle Assist Devices (LVAD). Further we analyzed if increased clinical experience would reduce total hospital costs and the gap between costs and the diagnosis related grouped (DRG)-reimbursement. METHOD: Cost data of 20 LVAD implantations (VentrAssist™) from 2005-2009 (period 1) were analyzed together with costs from nine patients using another LVAD (HeartWare™) from 2009-June 2011 (period 2). For each patient, total costs were calculated for three phases - the pre-LVAD implantation phase, the LVAD implantation phase and the post LVAD implant phase. Patient specific costs were obtained prospectively from patient records and included personnel resources, medication, blood products, blood chemistry and microbiology, imaging and procedure costs including operating room costs. Overhead costs were registered retrospectively and allocated to the specific patient by predefined allocation keys. Finally, patient specific costs and overhead costs were aggregated into total hospital costs for each patient. All costs were calculated in 2011-prices. We used regression analyses to analyze cost variations over time and between the different devices. RESULTS: The average total hospital cost per patient for the pre-LVAD, LVAD and post-LVAD for period 1 was $ 585, 513 (range 132, 640- 1 247, 299), and the corresponding DRG- reimbursement (2009) was $ 143, 192 . The mean LOS was 54 days (range 12- 127). For period 2 the total hospital cost per patient was $ 413, 185 (range 314, 540- 622, 664) and the corresponding DRG- reimbursement (2010) was $ 136, 963. The mean LOS was 49 days (range 31- 93). The estimates from the regression analysis showed that the total hospital costs, excluding device costs, per patient were falling as the number of treated patients increased. The estimate from the trend variable was -14, 096 US$ (CI -3, 842 to -24, 349, p < 0.01). CONCLUSION: There were significant reductions in total hospital costs per patient as the numbers of patients were increasing. This can possibly be explained by a learning effect including better logistics, selection and management of patients.
format Online
Article
Text
id pubmed-3515474
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35154742012-12-06 Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital Mishra, Vinod Fiane, Arnt E Geiran, Odd Sørensen, Gro Khushi, Ishtiaq Hagen, Terje P J Cardiothorac Surg Research Article BACKGROUND: The current study was undertaken to examine total hospital costs per patient of a consecutive implantation series of two 3(rd) generation Left Ventricle Assist Devices (LVAD). Further we analyzed if increased clinical experience would reduce total hospital costs and the gap between costs and the diagnosis related grouped (DRG)-reimbursement. METHOD: Cost data of 20 LVAD implantations (VentrAssist™) from 2005-2009 (period 1) were analyzed together with costs from nine patients using another LVAD (HeartWare™) from 2009-June 2011 (period 2). For each patient, total costs were calculated for three phases - the pre-LVAD implantation phase, the LVAD implantation phase and the post LVAD implant phase. Patient specific costs were obtained prospectively from patient records and included personnel resources, medication, blood products, blood chemistry and microbiology, imaging and procedure costs including operating room costs. Overhead costs were registered retrospectively and allocated to the specific patient by predefined allocation keys. Finally, patient specific costs and overhead costs were aggregated into total hospital costs for each patient. All costs were calculated in 2011-prices. We used regression analyses to analyze cost variations over time and between the different devices. RESULTS: The average total hospital cost per patient for the pre-LVAD, LVAD and post-LVAD for period 1 was $ 585, 513 (range 132, 640- 1 247, 299), and the corresponding DRG- reimbursement (2009) was $ 143, 192 . The mean LOS was 54 days (range 12- 127). For period 2 the total hospital cost per patient was $ 413, 185 (range 314, 540- 622, 664) and the corresponding DRG- reimbursement (2010) was $ 136, 963. The mean LOS was 49 days (range 31- 93). The estimates from the regression analysis showed that the total hospital costs, excluding device costs, per patient were falling as the number of treated patients increased. The estimate from the trend variable was -14, 096 US$ (CI -3, 842 to -24, 349, p < 0.01). CONCLUSION: There were significant reductions in total hospital costs per patient as the numbers of patients were increasing. This can possibly be explained by a learning effect including better logistics, selection and management of patients. BioMed Central 2012-08-27 /pmc/articles/PMC3515474/ /pubmed/22925716 http://dx.doi.org/10.1186/1749-8090-7-76 Text en Copyright ©2012 Mishra et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mishra, Vinod
Fiane, Arnt E
Geiran, Odd
Sørensen, Gro
Khushi, Ishtiaq
Hagen, Terje P
Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital
title Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital
title_full Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital
title_fullStr Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital
title_full_unstemmed Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital
title_short Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital
title_sort hospital costs fell as numbers of lvads were increasing: experiences from oslo university hospital
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515474/
https://www.ncbi.nlm.nih.gov/pubmed/22925716
http://dx.doi.org/10.1186/1749-8090-7-76
work_keys_str_mv AT mishravinod hospitalcostsfellasnumbersoflvadswereincreasingexperiencesfromoslouniversityhospital
AT fianearnte hospitalcostsfellasnumbersoflvadswereincreasingexperiencesfromoslouniversityhospital
AT geiranodd hospitalcostsfellasnumbersoflvadswereincreasingexperiencesfromoslouniversityhospital
AT sørensengro hospitalcostsfellasnumbersoflvadswereincreasingexperiencesfromoslouniversityhospital
AT khushiishtiaq hospitalcostsfellasnumbersoflvadswereincreasingexperiencesfromoslouniversityhospital
AT hagenterjep hospitalcostsfellasnumbersoflvadswereincreasingexperiencesfromoslouniversityhospital